Gastrointestinal Stromal Tumors

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract. These tumors are distinguished from leiomyosarcomas by the recognition that they contain both smooth and neural elements. In addition, these sarcomas are shown to express KIT and/or the platelet-derived growth factor receptor-α (PDGFRα). These tyrosine kinase receptors are commonly mutated, constitutively activating, and serve as the oncologic driver of these tumors. This biologic understanding has led to significant changes in the therapy of this disease, which has changed from a surgically treated disease to one that now incorporates therapy targeting the KIT and PDGFR tyrosine kinases.

Original languageEnglish
Title of host publicationTextbook of Uncommon Cancer, Third Edition
PublisherJohn Wiley & Sons, Ltd
Pages418-429
Number of pages12
ISBN (Print)0470012021, 9780470012024
DOIs
StatePublished - Jul 11 2006

Keywords

  • Gastrointestinal stromal tumors (GIST)
  • Imatinib mesylate
  • Imatinib mesylate resistance
  • KIT
  • PDGFR
  • Tyrosine kinase inhibitors

Fingerprint

Dive into the research topics of 'Gastrointestinal Stromal Tumors'. Together they form a unique fingerprint.

Cite this